Related references
Note: Only part of the references are listed.Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer
Katarzyna Lubecka-Pietruszewska et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Maternal Diet Supplementation with Methyl Donors and Increased Parity Affect the Incidence of Craniofacial Defects in the Offspring of Twisted gastrulation Mutant Mice
Charles J. Billington et al.
JOURNAL OF NUTRITION (2013)
Flavonoids, Flavonoid Subclasses and Breast Cancer Risk: A Meta-Analysis of Epidemiologic Studies
Chang Hui et al.
PLOS ONE (2013)
Can Soy Phytoestrogens Decrease DNA Methylation in BRCA1 and BRCA2 Oncosuppressor Genes in Breast Cancer?
Remy Bosviel et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis
Chang Hui et al.
BREAST CANCER RESEARCH (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Advances in the computational development of DNA methyltransferase inhibitors
Jose L. Medina-Franco et al.
DRUG DISCOVERY TODAY (2011)
DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines
Mawussi Adjakly et al.
EPIGENOMICS (2011)
Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics
Alexander Link et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation
Yanyuan Wu et al.
BMC CANCER (2010)
Impact on DNA Methylation in Cancer Prevention and Therapy by Bioactive Dietary Components
Y. Li et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines
Syed M. Meeran et al.
PLOS ONE (2010)
Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways
Gaoliang Ouyang et al.
CELL BIOLOGY INTERNATIONAL (2009)
Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms
Yuanyuan Li et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment
Amy M. Dworkin et al.
SEMINARS IN CANCER BIOLOGY (2009)
Multi-targeted therapy of cancer by genistein
Sanjeev Banerjee et al.
CANCER LETTERS (2008)
Cancer Prevention: Epigenetics Steps Up to the Plate
Jean-Pierre Issa
CANCER PREVENTION RESEARCH (2008)
Modulation of gene methylation by genistein or lycopene in breast cancer cells
Audrey King-Batoon et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2008)
Epigenomics and breast cancer
Pang-Kuo Lo et al.
PHARMACOGENOMICS (2008)
Breast cancer: origins and evolution
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2007)
Environmental epigenomics and disease susceptibility
Randy L. Jirtle et al.
NATURE REVIEWS GENETICS (2007)
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
SB Baylin et al.
NATURE REVIEWS CANCER (2006)
Reversal of hypermethylation and reactivation of p16INK4a RARβ, and MGMT genes by genistein and other isoflavones from soy
MZ Fang et al.
CLINICAL CANCER RESEARCH (2005)
Promoter methylation of the PTEN gene is a common molecular change in breast cancer
JM García et al.
GENES CHROMOSOMES & CANCER (2004)
The ATM gene is a target for epigenetic silencing in locally advanced breast cancer
QN Vo et al.
ONCOGENE (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Transposable elements: Targets for early nutritional effects on epigenetic gene regulation
RA Waterland et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Establishment and functional validation of a structural homology model for human DNA methyltransferase 1
P Siedlecki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
MF Robert et al.
NATURE GENETICS (2003)
5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation:: mechanistic studies and their implications for cancer therapy
JK Christman
ONCOGENE (2002)
Differences between human breast cell lines in susceptibility towards growth inhibition by genistein
K Dampier et al.
BRITISH JOURNAL OF CANCER (2001)
High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
AT Ferguson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
